These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 3898829)

  • 1. Islet-cell abnormalities in non-insulin-dependent diabetes mellitus.
    Raskin P
    Am J Med; 1985 Aug; 79(2B):2-5. PubMed ID: 3898829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells.
    Hamaguchi T; Fukushima H; Uehara M; Wada S; Shirotani T; Kishikawa H; Ichinose K; Yamaguchi K; Shichiri M
    Diabetologia; 1991 Nov; 34(11):801-6. PubMed ID: 1769438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose regulation in non-insulin-dependent diabetes mellitus. Interaction between pancreatic islets and the liver.
    Halter JB; Ward WK; Porte D; Best JD; Pfeifer MA
    Am J Med; 1985 Aug; 79(2B):6-12. PubMed ID: 2863979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental reduction of B-cell mass: implications for the pathogenesis of diabetes.
    Weir GC; Leahy JL; Bonner-Weir S
    Diabetes Metab Rev; 1986; 2(1-2):125-61. PubMed ID: 2424696
    [No Abstract]   [Full Text] [Related]  

  • 5. Islet dysfunction in non-insulin-dependent diabetes mellitus.
    Kahn SE; Porte D
    Am J Med; 1988 Nov; 85(5A):4-8. PubMed ID: 3057894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus.
    Ahrén B; Larsson H; Holst JJ
    J Clin Endocrinol Metab; 1997 Feb; 82(2):473-8. PubMed ID: 9024239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat.
    Tokuyama Y; Sturis J; DePaoli AM; Takeda J; Stoffel M; Tang J; Sun X; Polonsky KS; Bell GI
    Diabetes; 1995 Dec; 44(12):1447-57. PubMed ID: 7589853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-endorphin infusion restores acute insulin responses to glucose in type-2 diabetes mellitus.
    Giugliano D; Ceriello A; Salvatore T; Paolisso G; D'Onofrio F; Lefèbvre P
    J Clin Endocrinol Metab; 1987 May; 64(5):944-8. PubMed ID: 2951394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
    Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and glucagon secretion in streptozotocin-diabetic rats: influences of islets transplanted to the renal subcapsular space.
    Ar'Rajab A; Ahrén B; Bengmark S
    Diabetes Res; 1989 Sep; 12(1):37-41. PubMed ID: 2517050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of high carbohydrate intake on hyperglycemia, islet function, and plasma lipoproteins in NIDDM.
    Garg A; Grundy SM; Koffler M
    Diabetes Care; 1992 Nov; 15(11):1572-80. PubMed ID: 1468287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of insulin secretion in diabetes mellitus.
    Ward WK; Beard JC; Halter JB; Porte D
    Adv Exp Med Biol; 1985; 189():137-58. PubMed ID: 3898762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
    Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
    Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta- and alpha-cell dysfunction in type 2 diabetes.
    Del Prato S; Marchetti P
    Horm Metab Res; 2004; 36(11-12):775-81. PubMed ID: 15655708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-beta-cell islet abnormalities in noninsulin-dependent diabetes mellitus.
    Gerich JE; Campbell PJ; Kennedy FP
    Prog Clin Biol Res; 1988; 265():133-50. PubMed ID: 3043441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus.
    Kahn SE
    Am J Med; 2000 Apr; 108 Suppl 6a():2S-8S. PubMed ID: 10764844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The key role of islet dysfunction in type II diabetes mellitus.
    Porte D; Kahn SE
    Clin Invest Med; 1995 Aug; 18(4):247-54. PubMed ID: 8549009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal glucose modulation of islet A- and B-cell responses to arginine in non-insulin-dependent diabetes mellitus.
    Dimitriadis GD; Pehling GB; Gerich JE
    Diabetes; 1985 Jun; 34(6):541-7. PubMed ID: 3891467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes.
    Devedjian JC; George M; Casellas A; Pujol A; Visa J; Pelegrín M; Gros L; Bosch F
    J Clin Invest; 2000 Mar; 105(6):731-40. PubMed ID: 10727441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.